rs748523268
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The ENST00000526986.5(ZDHHC24):c.*219C>G variant causes a 3 prime UTR change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,613,636 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
ENST00000526986.5 3_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- Bardet-Biedl syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Myriad Women’s Health, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BBS1 | ENST00000318312.12 | c.724-1G>C | splice_acceptor_variant, intron_variant | Intron 8 of 16 | 1 | NM_024649.5 | ENSP00000317469.7 | |||
| ENSG00000256349 | ENST00000419755.3 | c.835-1G>C | splice_acceptor_variant, intron_variant | Intron 8 of 16 | 2 | ENSP00000398526.3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152246Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000835 AC: 21AN: 251460 AF XY: 0.0000883 show subpopulations
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1461390Hom.: 0 Cov.: 30 AF XY: 0.0000481 AC XY: 35AN XY: 727002 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74376 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome 1 Pathogenic:2
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Bardet-Biedl syndrome Pathogenic:1
This sequence change affects an acceptor splice site in intron 8 of the BBS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in BBS1 are known to be pathogenic (PMID: 12118255, 21520335, 27032803). This variant is present in population databases (rs748523268, gnomAD 0.07%). Disruption of this splice site has been observed in individual(s) with retinitis pigmentosa (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 552356). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at